Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v3-EN
Language English English
Date Updated 2022-09-10 2022-06-27
Drug Identification Number 02245571 02245571
Brand name BACIJECT 50,000 UNITS/VIAL BACIJECT 50,000 UNITS/VIAL
Common or Proper name BACIJECT 50,000 UNITS/VIAL BACIJECT 50,000 UNITS/VIAL
Company Name STERIMAX INC STERIMAX INC
Ingredients BACITRACIN BACITRACIN
Strength(s) 50000UNIT 50000UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration TOPICAL INTRAMUSCULAR TOPICAL INTRAMUSCULAR TOPICAL INTRAMUSCULAR TOPICAL INTRAMUSCULAR
Packaging size 10 VIALS 10 VIALS
ATC code J01XX J01XX
ATC description OTHER ANTIBACTERIALS OTHER ANTIBACTERIALS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2022-06-03 2022-06-03
Estimated end date 2022-09-09 2022-09-05
Actual end date 2022-09-09
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product will be available at McKesson by end of next week. This is due to a manufacturing delay. Inventory is available at McKesson.
Health Canada comments